Armatilco SRL
Armatilco reported total assets of €3.44m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Armatilco shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +69 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Armatilco's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Armatilco's financial analysis
- Solvency29.3%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Armatilco
Armatilco's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0873.590.512
- VAT number
- BE0873590512
- Peppol
- Registered · 0208:0873590512 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 May 2005
- Registered office
- 1340 Ottignies-Louvain-la-Neuve
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Armatilco (SRL) has been based in Ottignies-Louvain-la-Neuve since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 182,660 € and equity of €1.01m; its revenue is not published. Its solvency stands at 29.3%, below the median of its sector (40.1%).
Companies similar to Armatilco
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apovsk Retail sale of pharmaceutical products Kortrijk · balance sheet €2.26m
- ODRP Pharma Retail sale of pharmaceutical products Ghent · balance sheet €2.24m
- Sialka Retail sale of medical and orthopaedic goods Overijse · balance sheet €5.28m
- Apotheek Schellekens - Lauwers Retail sale of pharmaceutical products Schelle · balance sheet €1.84m
- APR.P.D. Retail sale of pharmaceutical products Hasselt · balance sheet €2.05m
- AGC Audio Retail sale of medical and orthopaedic goods Brussels · balance sheet €3.36m
- Varmaca Retail sale of pharmaceutical products Peer · balance sheet €2.03m
Frequently asked questions about Armatilco
What is the revenue of Armatilco?
Armatilco files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Armatilco?
In Belgium, the VAT number is the company number prefixed with BE: BE0873590512 for Armatilco, if the company is VAT-registered. Its company number (CBE) is 0873.590.512.
Where is the registered office of Armatilco?
According to the CBE register, the registered office of Armatilco is in 1340 Ottignies-Louvain-la-Neuve.
What is the equity of Armatilco?
At the close of the 2025 financial year, the equity of Armatilco amounts to 1,007,870 €, a solvency of 29.3% of total assets.
Who manages Armatilco?
The register lists 2 active mandates at Armatilco. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Armatilco
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →